These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15337704)

  • 61. Rate of progression of valvular aortic stenosis in patients undergoing dialysis.
    Kume T; Kawamoto T; Akasaka T; Watanabe N; Toyota E; Neishi Y; Wada N; Okahashi N; Yoshida K
    J Am Soc Echocardiogr; 2006 Jul; 19(7):914-8. PubMed ID: 16825002
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics.
    Sverdlov AL; Ngo DT; Chan WP; Chirkov YY; Gersh BJ; McNeil JJ; Horowitz JD
    Eur Heart J; 2012 Oct; 33(19):2419-25. PubMed ID: 22771677
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atherosclerosis, degenerative aortic stenosis and statins.
    Novo G; Fazio G; Visconti C; Carità P; Maira E; Fattouch K; Novo S
    Curr Drug Targets; 2011 Jan; 12(1):115-21. PubMed ID: 20863278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of statin therapy and angiotensin blockade in patients with asymptomatic moderate carotid artery stenosis.
    Durham CA; Ehlert BA; Agle SC; Mays AC; Parker FM; Bogey WM; Powell CS; Stoner MC
    Ann Vasc Surg; 2012 Apr; 26(3):344-52. PubMed ID: 22285349
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined renin-angiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study).
    Fujita M; Yamazaki T; Hayashi D; Kohro T; Okada Y; Nagai R;
    Am J Cardiol; 2007 Dec; 100(12):1750-3. PubMed ID: 18082520
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
    Jander N; Minners J; Holme I; Gerdts E; Boman K; Brudi P; Chambers JB; Egstrup K; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Rossebø A; Pedersen TR; Skjærpe T; Willenheimer R; Wachtell K; Neumann FJ; Gohlke-Bärwolf C
    Circulation; 2011 Mar; 123(8):887-95. PubMed ID: 21321152
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipid profile of patients with aortic stenosis might be predictive of rate of progression.
    Yilmaz MB; Guray U; Guray Y; Cihan G; Caldir V; Cay S; Kisacik HL; Korkmaz S
    Am Heart J; 2004 May; 147(5):915-8. PubMed ID: 15131551
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progression of asymptomatic carotid stenosis despite optimal medical therapy.
    Conrad MF; Boulom V; Mukhopadhyay S; Garg A; Patel VI; Cambria RP
    J Vasc Surg; 2013 Jul; 58(1):128-35.e1. PubMed ID: 23806255
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic effect of statin on aortic stenosis: a review with meta-analysis.
    Ge H; Zhang Q; Wang BY; He B
    J Clin Pharm Ther; 2010 Aug; 35(4):385-93. PubMed ID: 20831541
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Hemodynamic effects of oral captopril in patients with critical aortic stenosis].
    Martínez Sánchez C; Henne O; Arceo A; Peña M; González H; Chuquiure E; Lupi E
    Arch Inst Cardiol Mex; 1996; 66(4):322-30. PubMed ID: 8984953
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Statins in aortic stenosis: new data from a prospective clinical trial.
    Griffin BP
    J Am Coll Cardiol; 2007 Feb; 49(5):562-4. PubMed ID: 17276179
    [No Abstract]   [Full Text] [Related]  

  • 74. [Can we prevent the progression of aortic valve sclerosis and stenosis? The need for a prospective, randomized trial].
    Scardi S; Cherubini A
    Ital Heart J Suppl; 2005 Jul; 6(7):403-12. PubMed ID: 16082823
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
    Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
    Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Research progress on pharmacotherapy of calcific aortic valve disease].
    DU M; Ma G; Shi Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.
    Galindo-Ocaña J; Bernabeu-Wittel M; Formiga F; Fuertes-Martín A; Barón-Franco B; Murcia-Zaragoza JM; Moreno-Gaviño L; Ollero-Baturone M;
    Eur J Intern Med; 2012 Mar; 23(2):179-84. PubMed ID: 22284251
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of statins in aortic valve disease.
    Rajamannan NM
    Heart Fail Clin; 2006 Oct; 2(4):395-413. PubMed ID: 17448427
    [No Abstract]   [Full Text] [Related]  

  • 79. Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients.
    Teo KK; Corsi DJ; Tam JW; Dumesnil JG; Chan KL
    Can J Cardiol; 2011; 27(6):800-8. PubMed ID: 21742465
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Simvastatin reduces the TLR4-induced inflammatory response in human aortic valve interstitial cells.
    Venardos N; Deng XS; Yao Q; Weyant MJ; Reece TB; Meng X; Fullerton DA
    J Surg Res; 2018 Oct; 230():101-109. PubMed ID: 30100024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.